VAIOS Total Shoulder Replacement System 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Orthotech 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2015-10-23
  • 사례 출판 날짜
    2015-10-23
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: orthotech vaios total shoulder replacement system the therapeutic goods administration (tga) of australia has posted a medical device safety alert concerning vaios total shoulder replacement system, manufactured by orthotech. the manufacturer, in consultation with the tga, has issued a hazard alert for the vaios total shoulder replacement system due to higher than expected revision rates. the manufacturer ceased supply of the affected device on 14 august 2015 after cancellation from the australian register of therapeutic goods. information published by the australian orthopaedic association's national joint replacement registry (aoanjrr) indicated that, to december 2013, the affected device had a revision rate at two years of 17.6%. the comparable revision rate at two years for all other total conventional shoulder implants was 5.5%. this data indicated that, at december 2013, the affected device was four times more likely to need revision than other conventional shoulder implants. the tga analysed additional data from the aoanjrr collected to december 2014 and found that the revision rate of the implant was not improving. the manufacturer is advising clinicians to consider contacting patients who have been implanted with these devices to inform them of this issue. implanting surgeons are advised to maintain their routine follow-up protocol for patients who have undergone shoulder arthroplasty. the need for any additional follow-up or revision surgery should be determined on a case-by-case basis following a detailed assessment of the patient’s clinical circumstances. preventative removal of implanted devices is not recommended at this time, as the risks of additional surgery outweigh the benefits if no problems are being experienced by the patient. for details, please refer to the tga website:http://apps.Tga.Gov.Au/prod/sara/arn-detail.Aspx?k=rc-2015-rn-00976-1 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 23 october 2015.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Orthotech Vaios Total Shoulder Replacement System
  • Manufacturer

Manufacturer